NewsRoom Articles - BioMedWire (BMW)

MondaySep 25, 2023 1:17 pm

Inverse Vaccines Show Promise Against Autoimmunity

University of Chicago Pritzker School of Molecular Engineering (PME) researchers have developed a new vaccine that has completely reversed autoimmune disorders in laboratory settings. This “inverse vaccine” works by wiping out the immune system’s memory of a perceived irritant rather than suppressing the immune system to limit autoimmunity symptoms. The immune system is essentially a battle-ready system of defenses ready to attack and destroy any threats at the drop of a hat. In some people, the immune system is overly sensitive and will react aggressively after mistaking harmless substances such as proteins, pollen and healthy tissues, for threats. This results…

MondaySep 25, 2023 10:30 am

Trial Enrollment Growth Supports Plans of CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Complete Enrollment for Important Brain Cancer Drug Study

CNS Pharmaceuticals is conducting a global clinical trial to evaluate its flagship drug candidate for treating glioblastoma, a deadly brain cancer CNS has enrolled 200 of its planned 243 patients for its clinical trial roster, and anticipates filling out the remainder of patients by year’s end The company is also preparing the interim study analysis for release by year’s end, now that more than 50 percent of the planned patient roster has reached a point necessary for effective comparison of performance of the flagship drug, Berubicin, to that of a standard of care chemotherapy agent The company has stated that…

FridaySep 22, 2023 12:29 pm

Why Colon Cancer Is Largely Unresponsive to Immunotherapy

Colorectal cancer is the third-most common type of cancer among adults in the United States, affecting an estimated 106,970 people in 2023 and predicted to take more than 50,000 lives this year. Treatment often involves surgery to remove as much of the tumor as possible, followed by chemotherapy and radiation therapy to kill off any remaining tumor cells. Recent research published in the “Nature Genetics” journal has shed new light on why immunotherapy, a relatively new type of cancer treatment that uses a patient’s own immune system to kill cancer cells, isn’t as effective against colon cancers. Researchers studied the…

ThursdaySep 21, 2023 12:14 pm

Five Ways to Prep Your eCommerce Site for Success

E-commerce accounted for close to 19% of global retail sales in 2022 and was projected to reach a valuation of $5.5 trillion in sales by the end of the year. With tens of millions of e-commerce businesses competing to attract the billions of customers who purchase products online every year, you will need an inspired strategy to stand out from the pack and build an identifiable brand. Lessons learned from this year should inform your decision-making process as you move into 2024. Review data from this year’s campaigns and reports to see if you can glean any insights or spot…

WednesdaySep 20, 2023 12:06 pm

Nottingham University Researchers Find Way to Make Brain Cancer Cells Self-Destruct

Nottingham University researchers have devised a novel means of treating brain cancer that could signal a “quantum leap” in brain-tumor treatments moving forward. A multidisciplinary research team created a new way of targeting and eliminating cancer cells in typically hard-to-treat types of brain tumors that cause cancer cells to essentially self-destruct. This technique involves leveraging bio-nanoantenna, extremely tiny gold particles (nanoparticles) coated with redox active molecules that are specialized to bring about programmed cell death (apoptosis). Upon electrical stimulation, bio-nanoantenna can induce the self-destruction of brain tumor cells, giving physicians a potential treatment option with much higher chances of better…

WednesdaySep 20, 2023 11:15 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources

California-based cancer fighter Renovaro BioSciences is turning the power of its immune system-promoting technology to the fight against pancreatic cancer and other illnesses that tend to leave patients with a short life expectancy once they are diagnosed Renovaro recently announced a binding, exclusive letter of intent (“LOI”) to add GEDI Cube’s artificial intelligence (“AI”) data mining technology to its fight against such cancers GEDI Cube is strengthening its platform’s potential by joining with the NVIDIA Inception program, which nurtures start-ups by providing access to cutting-edge technology, technical resources, and venture capitalists The companies hope to detect pancreatic tumors at early…

WednesdaySep 20, 2023 9:00 am

Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology

U.S.-based generic drug developer SOHM is working to build its product pipeline through registration for distribution in several states and the planned establishment of its own product manufacturing plant in Southern California SOHM is also focused on developing a regenerative medicine portfolio, having issued an LOI recently in its bid to acquire the gene editing technology ABBIE from CGA Intellectual Holdings Inc. ABBIE is a synthetic enzyme technology that includes a DNA binding solution and a DNA integration solution for introducing a functionally edited genome into an “enhanced” cell that could then be introduced into a patient’s body to repair…

TuesdaySep 19, 2023 1:48 pm

Study Shows Climate Change Impacts Infectious Disease Risks

European researchers have published a study associating climate change with the prevalence of infectious disease transmission. The continent-wide study analyzed the prevalence of viruses, bacteria and protozoans that have the potential to infect humans, domestic animals and bats in various climates. The researchers found that rainfall and temperature could affect the prevalence of several potentially pathogenic microorganisms. They investigated more than 75 microbes from an estimated 40 bat and 400 bird species across the European continent and compared their prevalence to different climatic conditions. Increased temperatures and extreme weather events often come to mind when most people think about the…

MondaySep 18, 2023 11:48 am

UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors

New research from the University of Illinois suggests that scientists can leverage the immune system to combat more types of cancer than previous research indicated. A recent study analyzing the effectiveness of treatments that use chimeric antigen receptor T cells to fight cancer cells found that cancer therapies that involve modifying CAR-T cells to improve their anticancer capabilities may also be effective at fighting solid tumors. Past research and plenty of real-world evidence have consistently shown that cancers without solid tumors such as lymphoma and leukemia can be treated through immunotherapies. However, this treatment exhibited barely any effectiveness against cancers…

FridaySep 15, 2023 2:20 pm

Five Considerations When Taking eCommerce Brands Global

For any new company looking to succeed in this age of virtual trade, finding ways to stand out from the rest of the pack will be integral to building a successful brand, especially on the global stage. Adapting your branding to unique audiences should be your first consideration when launching products in foreign markets. This may include researching local cultures and understanding the language and any symbolism locals may place with certain names, packaging or colors. American beauty product and skincare company Estée Lauder learned this lesson when it launched a project in Germany without realizing that the product’s name…